Published in J Cell Physiol on August 01, 1986
Rapid regulation of c-myc protooncogene expression by progesterone in the avian oviduct. Proc Natl Acad Sci U S A (1988) 0.83
Rapid induction of the c-jun protooncogene in the avian oviduct by the antiestrogen tamoxifen. Proc Natl Acad Sci U S A (1991) 0.77
Participation of c-myc protein in DNA synthesis of human cells. Science (1986) 2.22
Selective inhibition of the cell cycle of cultured human diploid fibroblasts by aminonucleoside of puromycin. J Cell Physiol (1973) 1.50
Thymidine as a synchronizing agent. I. Nucleic acid and protein formation in synchronous HeLa cultures treated with excess thymidine. J Cell Physiol (1969) 1.45
Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res (1996) 1.45
Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells. J Cell Biochem (2001) 1.34
Correlation between cell enlargement and nucleic acid and protein content of HeLa cells in unbalanced growth produced by inhibitors of DNA synthesis. J Cell Physiol (1967) 1.21
An autoradiographic screening test for mycoplasmal contamination of mammalian cell cultures. In Vitro (1973) 1.16
Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents. J Natl Cancer Inst (2001) 1.15
Thymidine as a synchronizing agent. II. Partial recovery of HeLa cells from unbalanced growth. J Cell Physiol (1969) 1.07
Inhibition of p38 MAP kinase activity up-regulates multiple MAP kinase pathways and potentiates 1,25-dihydroxyvitamin D(3)-induced differentiation of human leukemia HL60 cells. Exp Cell Res (2000) 1.05
Thymidine as synchronizing agent. 3. Persistence of cell cycle patterns of phosphatase activities and elevation of nuclease activity during inhibition of DNA synthesis. J Cell Physiol (1970) 1.04
A system for monocytic differentiation of leukemic cells HL 60 by a short exposure to 1,25-dihydroxycholecalciferol. Proc Soc Exp Biol Med (1985) 1.03
Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells. J Cell Biochem (2001) 0.99
Cell cycle sensitivity of HL-60 cells to the differentiation-inducing effects of 1-alpha,25-dihydroxyvitamin D3. Cancer Res (1985) 0.97
Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein. J Cell Biochem (1997) 0.96
Teniposide induces nuclear but not mitochondrial DNA degradation. Cancer Res (1992) 0.96
Expression of the neuronal cyclin-dependent kinase 5 activator p35Nck5a in human monocytic cells is associated with differentiation. Blood (2001) 0.95
Phosphorylation of raf-1 by kinase suppressor of ras is inhibited by "MEK-specific" inhibitors PD 098059 and U0126 in differentiating HL60 cells. Exp Cell Res (2001) 0.93
Differentiation-related mechanisms which suppress DNA replication. Exp Cell Res (1999) 0.93
Synergistic induction of HL60 cell differentiation by ketoconazole and 1-desoxy analogues of vitamin D3. J Natl Cancer Inst (1997) 0.93
Translational study of vitamin D differentiation therapy of myeloid leukemia: effects of the combination with a p38 MAPK inhibitor and an antioxidant. Leukemia (2005) 0.92
Antiapoptotic action of 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c. Exp Cell Res (1997) 0.91
Induction of kinase suppressor of RAS-1(KSR-1) gene by 1, alpha25-dihydroxyvitamin D3 in human leukemia HL60 cells through a vitamin D response element in the 5'-flanking region. Oncogene (2006) 0.91
Loss of deoxcytidine kinase expression and tetraploidization of HL60 cells following long-term culture in 1,25-dihydroxyvitamin D3. Exp Cell Res (1996) 0.90
Relationship between RNA synthesis, cell division, and morphology of mammalian cells. I. Puromycin aminonucleoside as an inhibitor of RNA synthesis and division in HeLa cells. J Cell Biol (1966) 0.89
Cytologic appearance of the nucleolus of normal and neoplastic cells in relation to the synthesis of RNA. Acta Cytol (1972) 0.87
A correlated morphological and functional study of the effects of actinomycin D on HeLa cells. I. Effects on the nucleolar and cytoplasmic ribonucleoproteins. Exp Cell Res (1967) 0.86
Highly active analogs of 1alpha,25-dihydroxyvitamin D(3) that resist metabolism through C-24 oxidation and C-3 epimerization pathways. Steroids (2001) 0.86
Mitomycin C induced increases in the activities of the deoxyribonucleases of HeLa cells. Biochem Biophys Res Commun (1966) 0.85
Differences between diploid and heteroploid cultured mammalian cells in their response to puromycin aminonucleoside. Cancer Res (1968) 0.85
Constitutive DNA binding of the low mobility forms of the AP-1 and SP-1 transcription factors in HL60 cells resistant to 1-beta-D-arabinofuranosylcytosine. Cancer Res (1994) 0.84
1,25-Dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Exp Cell Res (1993) 0.83
Autoradiographic studies of the effects of inhibitors of protein synthesis on RNA synthesis in HeLa cells. Exp Cell Res (1968) 0.83
Instability of puromycin. Nature (1966) 0.83
Selective inhibition of preribosomal RNA synthesis by puromycin aminonucleoside in transformed human fibroblasts: studies of the nature of the inhibition in isolated nuclei and nucleoli. J Cell Physiol (1979) 0.83
Ectopic expression of truncated Sp1 transcription factor prolongs the S phase and reduces the growth rate. Anticancer Res (2000) 0.82
p53/56(lyn) antisense shifts the 1,25-dihydroxyvitamin D3-induced G1/S block in HL60 cells to S phase. J Cell Physiol (2000) 0.82
Lowering of p27Kip1 levels by its antisense or by development of resistance to 1,25-dihydroxyvitamin D3 reverses the G1 block but not differentiation of HL60 cells. Leukemia (1998) 0.82
Coordinate expression of c-myc, c-myb, and histone H4 genes in reversibly differentiating HL 60 cells. J Cell Physiol (1987) 0.82
Long-term exposure of HL60 cells to 1,25-dihydroxyvitamin D3 reduces their tumorigenicity: a model for cancer chemoprevention. Proc Soc Exp Biol Med (1997) 0.81
Resistance of mitochondrial DNA to degradation characterizes the apoptotic but not the necrotic mode of human leukemia cell death. J Cell Biochem (1993) 0.81
Changes in proto-oncogene expression associated with reversal of macrophage-like differentiation of HL 60 cells. J Natl Cancer Inst (1987) 0.81
Potentiation by 1-alpha,25-dihydroxyvitamin D3 of cytotoxicity to HL-60 cells produced by cytarabine and hydroxyurea. J Natl Cancer Inst (1986) 0.80
A dual block to cell cycle progression in HL60 cells exposed to analogues of vitamin D3. Cell Prolif (1994) 0.80
Definition of the cell cycle segment with special sensitivity to vinblastine. Proc Soc Exp Biol Med (1978) 0.79
Increased expression of oncogene c-Ha-ras during granulocytic differentiation of HL60 cells. Lab Invest (1987) 0.79
Methods for assessment of DNase activity. Methods Cell Biol (1978) 0.79
Truncation of Sp1 transcription factor by myeloblastin in undifferentiated HL60 cells. J Cell Physiol (1998) 0.79
Specific association of increased cyclin-dependent kinase 5 expression with monocytic lineage of differentiation of human leukemia HL60 cells. J Leukoc Biol (2000) 0.79
Cyclin-dependent kinase 6 is the principal target of p27/Kip1 regulation of the G1-phase traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells. Cancer Res (1997) 0.78
Inhibition by 1,25 dihydroxyvitamin D3 of chemically induced erythroid differentiation of K562 leukemia cells. Blood (1991) 0.78
Changes in the expression of oncogenes encoding nuclear phosphoproteins but not c-Ha-ras have a relationship to monocytic differentiation of HL 60 cells. J Cell Biol (1986) 0.78
Purification and properties of a nuclear DNA endonuclease from HeLa S3 cells. Biochim Biophys Acta (1979) 0.78
Use of antimetabolites in the study of normal and abnormal cell structure and function. Fed Proc (1966) 0.78
Visualization of nucleolar substructure in cultured human fibroblasts by magnesium-activated adenosine triphosphatase reaction. J Histochem Cytochem (1981) 0.78
Cyclin-dependent kinase 5 activity enhances monocytic phenotype and cell cycle traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells. Exp Cell Res (1999) 0.78
Enhancement of the affinity of nucleoli and chromosomes for zinc by treatment with chromic acid. Stain Technol (1967) 0.78
Up-regulation of Ca2+ influx mediated by store-operated channels in HL60 cells induced to differentiate by 1 alpha,25-dihydroxyvitamin D3. J Cell Physiol (1997) 0.78
Nuclear, nucleolinar and cytoplasmic acidphosphatases in cultured mammalian cells. Exp Cell Res (1969) 0.78
Resolution of multiple AP-1 complexes in HL-60 cells induced to differentiate by 1,25-dihydroxyvitamin D3. J Cell Physiol (1993) 0.77
Elevation of deoxyribonuclease activities in HeLa cells treated with selective inhibitors of DNA synthesis. Biochem Biophys Res Commun (1966) 0.77
Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase. Oncogene (1998) 0.77
Activation of DNA primer for DNA polymerase as an ultrasensitive assay for a subgroup of enzymes with deoxyribonuclease activity. Anal Biochem (1974) 0.77
Multiple deoxyribonuclease activities in nuclei of HeLa cells. Biochem Biophys Res Commun (1973) 0.77
Absence of aminonucleoside-sensitive steps in the cell cycle of SV40-transformed human fibroblasts. Cancer Res (1973) 0.77
Butyrate-induced G2/M block in Caco-2 colon cancer cells is associated with decreased p34cdc2 activity. Proc Soc Exp Biol Med (1999) 0.77
DNA endonuclease activities associated with melanoma cell chromatin. Biochem Biophys Res Commun (1979) 0.77
Enhanced messenger RNA stability and differentiation of HL 60 cells treated with 1,25-dihydroxyvitamin D3 and cordycepin. J Cell Physiol (1989) 0.77
Differentiation-related regulation of 1,25-dihydroxyvitamin D3 receptor mRNA in human leukaemia cells HL-60. Cell Prolif (1991) 0.77
Expression of monocyte-specific oncogenes c-fos and c-fms in HL60 cells treated with vitamin D3 analogs correlates with inhibition of DNA synthesis and reduced calmodulin concentration. Lab Invest (1986) 0.76
Vitamin D analog 25-(OH)-16,23E-Diene-26,27-hexafluoro-vitamin D3 induces differentiation of HL60 cells with minimal effects on cellular calcium homeostasis. J Cell Biochem (1996) 0.76
Inhibition by puromycin of incorporation of tritiated uridine into nucleolar and cytoplasmic ribonucleic acids. Nature (1966) 0.76
Metabolic differences between normal and neoplastic cells: effects of aminonucleoside on cytoplasmic messenger RNA. Science (1974) 0.76
Chromatin-associated DNA endonuclease activities in HeLa cells. Biochem Biophys Res Commun (1974) 0.76
Changes in E2F binding after phenylbutyrate-induced differentiation of Caco-2 colon cancer cells. Clin Cancer Res (2000) 0.76
Resistance to 1,25-dihydroxyvitamin D3 of a deoxycytidine kinase-deficient variant of human leukemia HL60 cells. Exp Cell Res (1992) 0.76
1,25-dihydroxyvitamin D(3)-induced retardation of the G(2)/M traverse is associated with decreased levels of p34(cdc2) in HL60 cells. J Cell Biochem (1999) 0.75
Recovery from prolonged ungalances growth induced in HeLa cells by high concentrations of thymidine. Cancer Res (1967) 0.75
Mitochondrial nucleic acids as internal standards for blot hybridization analyses. Anal Biochem (1992) 0.75
Basis for the differential action of aminonucleoside on normal and transformed human fibroblasts. J Natl Cancer Inst (1982) 0.75
Inhibition by 1,25 dihydroxyvitamin D3 of c-myc down-regulation and DNA fragmentation in cytosine arabinoside-induced erythroid differentiation of K562 cells. J Cell Physiol (1992) 0.75
Molecular basis of cell proliferation: the cell cycle. Ann Clin Lab Sci (1974) 0.75
Effect of aminonucleoside on serum stimulation of nonhistone nuclear protein and DNA synthesis in normal and SV40-transformed human fibroblats. Cancer Res (1974) 0.75
Fibroblasts transformed by an oncogenic virus show decreased uptake of puromycin aminonucleoside. Biochem Biophys Res Commun (1980) 0.75
Effect of aminonucleoside on transcription, methylation, and maturation of ribosomal RNA in SV40-transformed human lung fibroblasts. J Cell Physiol (1981) 0.75
Contribution of aminoacyl-transfer ribonucleic and to protein label in autoradiographic experiments. J Histochem Cytochem (1967) 0.75
Increased stringency of the 1,25-dihydroxyvitamin D3-induced G1 to S phase block in polyploid HL60 cells. J Cell Physiol (1996) 0.75
Nascent RNA chain termination and ultrastructural changes in nucleoli isolated from SV40-transformed fibroblasts treated with aminonucleoside of puromycin. Lab Invest (1980) 0.75
Metabolism of puromycin aminonucleoside in transformed human lung fibroblasts and the mechanism of its inhibition of RNA synthesis. Mol Pharmacol (1980) 0.75
DNA dependence and inhibition by novobiocin and coumermycin of the nucleolar adenosine triphosphatase (ATPase) of human fibroblasts. J Histochem Cytochem (1982) 0.75
Vitamin D analogs inhibit erythroid differentiation and induce monocytic differentiation of leukemic cells with the same relative potency. Proc Soc Exp Biol Med (1991) 0.75